JP2010506844A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506844A5
JP2010506844A5 JP2009532504A JP2009532504A JP2010506844A5 JP 2010506844 A5 JP2010506844 A5 JP 2010506844A5 JP 2009532504 A JP2009532504 A JP 2009532504A JP 2009532504 A JP2009532504 A JP 2009532504A JP 2010506844 A5 JP2010506844 A5 JP 2010506844A5
Authority
JP
Japan
Prior art keywords
leu
arg
val
glu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009532504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506844A (ja
JP5200027B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/080367 external-priority patent/WO2008048784A1/en
Publication of JP2010506844A publication Critical patent/JP2010506844A/ja
Publication of JP2010506844A5 publication Critical patent/JP2010506844A5/ja
Application granted granted Critical
Publication of JP5200027B2 publication Critical patent/JP5200027B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009532504A 2006-10-13 2007-10-04 Pth受容体モジュレーターとしてのペグ化pthおよびその使用 Expired - Fee Related JP5200027B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82938306P 2006-10-13 2006-10-13
US60/829,383 2006-10-13
PCT/US2007/080367 WO2008048784A1 (en) 2006-10-13 2007-10-04 Pegylated pth as pth receptor modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2010506844A JP2010506844A (ja) 2010-03-04
JP2010506844A5 true JP2010506844A5 (enExample) 2010-10-07
JP5200027B2 JP5200027B2 (ja) 2013-05-15

Family

ID=42828673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009532504A Expired - Fee Related JP5200027B2 (ja) 2006-10-13 2007-10-04 Pth受容体モジュレーターとしてのペグ化pthおよびその使用

Country Status (16)

Country Link
US (1) US7820179B2 (enExample)
EP (1) EP2084183B1 (enExample)
JP (1) JP5200027B2 (enExample)
KR (1) KR101108354B1 (enExample)
CN (1) CN101522709B (enExample)
AT (1) ATE469173T1 (enExample)
AU (1) AU2007313001B2 (enExample)
BR (1) BRPI0719885B8 (enExample)
CA (1) CA2672907C (enExample)
DK (1) DK2084183T3 (enExample)
EA (1) EA014696B1 (enExample)
MX (1) MX2009003740A (enExample)
NO (1) NO341986B1 (enExample)
PL (1) PL2084183T3 (enExample)
SI (1) SI2084183T1 (enExample)
WO (1) WO2008048784A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016065042A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
BR112018017091A2 (pt) 2016-03-01 2019-01-02 Ascendis Pharma Bone Diseases As profármacos de pth
NZ751745A (en) * 2016-09-29 2023-05-26 Ascendis Pharma Bone Diseases As Pth compounds with low peak-to-trough ratios
ES3012647T3 (en) 2016-09-29 2025-04-09 Ascendis Pharma Bone Diseases As Controlled-release pth compounds
CN109789189B (zh) 2016-09-29 2024-01-23 阿森迪斯药物骨疾病股份有限公司 控释pth化合物的剂量方案
EP3796941A4 (en) * 2018-05-30 2022-12-28 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
KR102891411B1 (ko) 2019-02-11 2025-11-25 아센디스 파마 본 디지즈 에이/에스 Pth 접합체의 액체 약학 제제
JP2025534350A (ja) 2022-09-30 2025-10-15 エクステンド バイオサイエンシズ インコーポレーテッド 長時間作用型副甲状腺ホルモン

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2550204B1 (fr) 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
JPS6360940A (ja) 1986-09-01 1988-03-17 Toyo Jozo Co Ltd 白内障の予防または治療剤
US4771124A (en) 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
JPH05271279A (ja) 1991-08-07 1993-10-19 Takeda Chem Ind Ltd ヒト副甲状腺ホルモンムテインおよびその製造法
US5814603A (en) 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US6110892A (en) 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5556940A (en) 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
CA2178894A1 (en) 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US6544949B1 (en) 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US5955574A (en) 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
ATE253078T1 (de) 1996-08-02 2003-11-15 Ca Nat Research Council Analoge des parathormons zur behandlung der osteoporose
CA2290443A1 (en) * 1997-05-14 1998-11-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Peptide parathyroid hormone analogs
CA2306344A1 (en) * 1997-10-14 1999-04-22 Masahiko Sato Method of building and maintaining bone
EP1950224A3 (en) 1998-03-09 2008-12-17 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
CN1163504C (zh) 1998-04-15 2004-08-25 阿温蒂斯药物公司 制备与树脂结合的环状肽的方法
AU3673699A (en) 1998-05-05 1999-11-23 Beth Israel Deaconess Medical Center Pth2 receptor selective compounds
US6316410B1 (en) 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
AU7734800A (en) 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
US7022815B1 (en) 1999-09-29 2006-04-04 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
US20050124537A1 (en) 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
CA2454275C (en) 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
JPWO2003064462A1 (ja) * 2002-02-01 2005-05-26 中外製薬株式会社 Peg結合pth又はpeg結合pth誘導体
WO2003105772A2 (en) 2002-06-13 2003-12-24 Beth Israel Deaconess Medical Center, Inc. Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
TW533925U (en) 2002-09-26 2003-05-21 Lee Yeong Ind Co Ltd Improvement of speed-changing transmission mechanism for cutting tools of drill sharpening machine
AU2002359391A1 (en) 2002-11-01 2004-07-29 Amgen, Inc. Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
KR101025143B1 (ko) 2002-12-31 2011-04-01 넥타르 테라퓨틱스 가수분해상으로 안정한 말레이미드-종결 중합체
WO2004084918A1 (ja) * 2003-03-25 2004-10-07 Sekisui Chemical Co., Ltd. 皮膚止痒外用組成物
US20040220094A1 (en) 2003-05-01 2004-11-04 Skinner Keith K. Inverse agonist and agonist peptides that stimulate/inhibit hair growth
WO2005072277A2 (en) 2004-01-21 2005-08-11 Unigene Laboratories Inc. Amidated parathyroid hormone fragments and uses thereof

Similar Documents

Publication Publication Date Title
JP2010506844A5 (enExample)
JP2009510025A5 (enExample)
RU2506274C2 (ru) Способы скрининга с применением g-белок сопряженных рецепторов и родственных композиций
JP2011524420A5 (enExample)
JP2008529558A5 (enExample)
ES2324153T3 (es) Motivo de union a integrina que contiene peptidos y metodo para el tratamiento de enfermedades del esqueleto.
CN1254347A (zh) 甲状旁腺素的类似物
ES2310187T3 (es) Productos dentales que comprenden un peptido que potencia el crecimiento oseo.
Seguin et al. The earliest dental prosthesis in Celtic Gaul? The case of an Iron Age burial at Le Chêne, France
AU2001283268A1 (en) Dental products comprising bone growth enhancing peptide
JP2012528887A5 (enExample)
WO2013054329A1 (en) Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
JP2008534485A (ja) スタテリンペプチドおよび薬剤における使用
JP2003516417A5 (enExample)
JP5047323B2 (ja) 生理活性ペプチド及びこれを含有する薬剤
JP2012501351A5 (enExample)
AU2018214650B2 (en) Compounds, compositions and uses thereof for improvement of bone disorders
JP2009507077A5 (enExample)
EP1619204A1 (en) PTH-like peptides
JP2014515751A5 (enExample)
JP2010533129A (ja) 部位特異的なペグ化をされた直鎖状のサケカルシトニン類似体
CN100336827C (zh) 中国南海信号芋螺神经毒素及其编码序列和用途
AU2015202418B2 (en) Designer osteogenic proteins
Rajendra et al. Ellis-van Creveld syndrome
Pakfetrat et al. Gorlin-Goltz Syndrome